Inhaled alternatives to nitric oxide.
Lowson
Stuart M
SM
Department of Anesthesiology, University of Virginia Health System, Charlottesville, Virginia 22908, USA. sml4s@virginia.edu
D000280:Administration, Inhalation; D000527:Alprostadil / Q000008:administration & dosage; D000818:Animals; D011464:Epoprostenol / Q000008:administration & dosage; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D016285:Iloprost / Q000008:administration & dosage; D009569:Nitric Oxide / Q000008:administration & dosage*; D005996:Nitroglycerin / Q000008:administration & dosage; D009599:Nitroprusside / Q000008:administration & dosage; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage; D011652:Pulmonary Circulation / Q000187:drug effects; D012128:Respiratory Distress Syndrome / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000008:administration & dosage*
D010726:Phosphodiesterase Inhibitors; D014665:Vasodilator Agents; D009599:Nitroprusside; D009569:Nitric Oxide; D011464:Epoprostenol; D000527:Alprostadil; D005996:Nitroglycerin; D016285:Iloprost